Key Insights

Highlights

Treatment Research

7 treatments under study, led by Intracytoplasmic Sperm Injection And Artificial Oocyte Activation

Related Conditions

Often studied with 7 related conditions

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 100/100

Termination Rate

25.0%

1 terminated out of 4 trials

Success Rate

0.0%

-86.6% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

1 of 0 completed with results

Key Signals

1 with results0

Data Visualizations

Phase Distribution

4Total
Not Applicable (2)
Phase 1/2 (1)
Phase 2/3 (1)

Trial Status

Recruiting2
Terminated1
Unknown1

Clinical Trials (4)

Showing 4 of 4 trials
NCT06561451Not ApplicableRecruiting

Live Birth Rate Between ICSI and AOA and ICSI Alone in Patients With Severe Teratospermia

NCT06869863Phase 1/2Recruiting

Study of Tolerability, Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of the Medicinal Product MediReg®

NCT01856361Not ApplicableTerminated

Ramipril for the Treatment of Oligospermia

NCT02063256Phase 2/3Unknown

7 NUTS Study. Diet Modification and Male Fertility.

Showing all 4 trials

Research Network

Common Treatments

  • Intracytoplasmic Sperm Injection And Artificial Oocyte Activation1
  • Ramipril1
  • Clostilbegit Clomiphene 50 Mg 1 Tablet X 1 P A Day 3 Months Triovit 1 Tablet X 1 P A Day 3 Months Folic Acid 1 Tablet X 1 P A Day 3 Months1
  • 7 Nuts A Day1
  • Diet Modification1

Active Sponsors

  • Weill Medical College of Cornell University1
  • Lomonosov Moscow State University Medical Research and Educational Center1
  • ShangHai Ji Ai Genetics & IVF Institute1
  • A.O.U. Città della Salute e della Scienza1

Top Investigators

Related Conditions

  • Oligospermia3
  • Male Infertility2
  • Asthenospermia1
  • Azoospermia Nonobstructive1
  • Male Subfertility1

Activity Timeline